Aug 7
|
Axsome Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update
|
Aug 5
|
3 Fantastic Growth Stocks to Buy in August
|
Aug 3
|
Got $5,000? These 2 Stocks Could Be Bargain Buys for 2023 and Beyond
|
May 10
|
2 Magnificent Growth Stocks You Can Buy With $150 Right Now
|
May 9
|
Axsome's New Drug Is Scoring a Win. Is the Stock a Buy?
|
May 9
|
Axsome (AXSM) Q1 Earnings Beat Estimates, Auvelity Volume Rises
|
May 9
|
Q1 2023 Axsome Therapeutics Inc Earnings Call
|
May 8
|
Axsome Therapeutics Clocks Better Than Expected Q1 Sales, Depression Drug Sees Improved Coverage
|
May 8
|
Axsome Therapeutics (AXSM) Q1 2023 Earnings Call Transcript
|
May 8
|
Axsome Therapeutics Reports First Quarter 2023 Financial Results and Corporate Update
|
May 4
|
7 High-Potential Penny Stocks in the Biotech Sector
|
May 3
|
Axsome Therapeutics to Present at the Bank of America Securities 2023 Healthcare Conference
|
May 1
|
Axsome Therapeutics Joins Mental Health America and the State of New York to Raise Awareness of Mental Health During May is Mental Health Month
|
Apr 28
|
The 3 Most Promising Biotech Innovations in 2023 and the Stocks to Buy
|
Apr 8
|
A New Nasdaq Bull Market Is Nearly Here: 3 Stocks to Buy Sooner Rather Than Later
|
Apr 5
|
Has Axsome Therapeutics Become a No-Brainer Buy?
|
Apr 4
|
Why Agenus, Amarin, and Axsome Therapeutics Shares Slumped Today
|
Apr 4
|
2 Top Biotech Stocks to Buy in April
|